Citadel Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.4M | Buy |
|
|||||
|
2025
Q1 | $1.35M | Sell |
|
|||||
|
2024
Q4 | $6.02M | Buy |
|
|||||
|
2024
Q3 | $4.96M | Buy |
|
|||||
|
2024
Q2 | $1.02M | Sell |
|
|||||
|
2024
Q1 | $2.08M | Sell |
|
|||||
|
2023
Q4 | $3.77M | Buy |
|
|||||
|
2023
Q3 | $1.43M | Sell |
|
|||||
|
2023
Q2 | $2.84M | Buy |
|
|||||
|
2023
Q1 | $1.39M | Sell |
|
|||||
|
2022
Q4 | $3.25M | Buy |
|
|||||
|
2022
Q3 | $2.58M | Sell |
|
|||||
|
2022
Q2 | $3.49M | Buy |
|
|||||
|
2022
Q1 | $2.42M | Buy |
|
|||||
|
2021
Q4 | $798K | Buy |
|
|||||
|
2021
Q3 | $292K | Sell |
|
|||||
|
2021
Q2 | $1.69M | Sell |
|
|||||
|
2021
Q1 | $18.9M | Sell |
|
|||||
|
2020
Q4 | $18.8M | Sell |
|
|||||
|
2020
Q3 | $16.5M | Buy |
|
|||||
|
2020
Q2 | $18M | Buy |
|
|||||
|
2020
Q1 | $8.08M | Buy |
|
|||||
|
2019
Q4 | $4.05M | Sell |
|
|||||
|
2019
Q3 | $3.14M | Sell |
|
|||||
|
2019
Q2 | $5.04M | Buy |
|
|||||
|
2019
Q1 | $2.27M | Buy |
|
|||||
|
2018
Q4 | $1.02M | Sell |
|
|||||
|
2018
Q3 | $1.37M | Sell |
|
|||||
|
2018
Q2 | $1.55M | Buy |
|